World's Best Scientists 2026 revealed!
Josep M. Grinyó

Josep M. Grinyó

D-Index & Metrics

Medicine

D-Index
82
Citations
25763
World Ranking
16075
National Ranking
225

Overview

Josep M. Grinyó is affiliated with the University of Barcelona in Spain. Their research focuses primarily on Medicine, with an emphasis on Transplantation. Over the course of their career, they have contributed extensively to various subfields including Transplantation, Pediatrics, Perinatology and Child Health, Surgery, Epidemiology, and Public Health, Environmental and Occupational Health.

The main topics covered in their work include:

  • Renal Transplantation Outcomes and Treatments
  • Pharmacological Effects and Toxicity Studies
  • Organ Transplantation Techniques and Outcomes
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • Organ Donation and Transplantation
  • Organ and Tissue Transplantation Research

Frequent publication venues for their research include:

  • Transplant International
  • Frontiers in Immunology
  • Pharmaceutics
  • American Journal of Transplantation
  • Frontiers in Pharmacology

Frequent co-authors collaborating with Josep M. Grinyó are:

  • Edoardo Melilli
  • Oriol Bestard
  • Núria Lloberas
  • Josep M. Cruzado
  • Pere Fontova

Selected recent papers authored or co-authored by Josep M. Grinyó include:

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, 2020, The Lancet
  • Immunosuppressive drugs modes of action, 2021, Best Practice & Research Clinical Gastroenterology
  • Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial, 2021, American Journal of Transplantation
  • Surrogate Endpoints for Late Kidney Transplantation Failure, 2022, Transplant International
  • A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction, 2023, Kidney International

Best Publications

  • Reduced exposure to calcineurin inhibitors in renal transplantation.

    Henrik Ekberg;Helio Tedesco-Silva;Alper Demirbas;Štefan Vítko

  • PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

    J Grinyo;C Groth;R Pichlmayr;Sa Sadek

  • Costimulation blockade with belatacept in renal transplantation.

    Flavio Vincenti;Christian Larsen;Antoine Durrbach;Thomas Wekerle

  • Belatacept and Long-Term Outcomes in Kidney Transplantation.

    Flavio Vincenti;Lionel Rostaing;Joseph Grinyo;Kim Rice

  • Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

    Henri Kreis;Jean-Marc Cisterne;Walter Land;Lars Wramner

  • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)

    A. Durrbach;J. M. Pestana;T. Pearson;F. Vincenti

  • Early Experience with Dual Kidney Transplantation in Adults using Expanded Donor Criteria

    Giuseppe Remuzzi;Josep Grinyò;Piero Ruggenenti;Marco Beatini

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

    Birgit Sawitzki;Paul N Harden;Petra Reinke;Aurélie Moreau

  • Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation

    Henrik Ekberg;C Bernasconi;H Tedesco-Silva;S Vítko

  • Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss

    F. Moreso;M. Ibernon;M. Gomà;M. Carrera

  • A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

    F. Vincenti;F. P. Schena;S. Paraskevas;I. A. Hauser

  • Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study

    Henrik Ekberg;J Grinyó;B Nashan;Y Vanrenterghem

  • Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

    F Vincenti;E Ramos;C Brattstrom;S Cho

  • Early protocol renal allograft biopsies and graft outcome

    Daniel Serón;Francesc Moreso;Jordi Bover;Enric Condom

  • Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

    J. O. Medina Pestana;J. M. Grinyo;Y. Vanrenterghem;T. Becker

  • Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

    Núria Lloberas;Josep M. Cruzado;Marcella Franquesa;Immaculada Herrero-Fresneda

  • Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation

    Rainer Oberbauer;Giuseppe Segoloni;Josep M Campistol;Henri Kreis

  • The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.

    Stuart Flechner;Maciej Glyda;Sandra Cockfield;Josep María Grinyõ

  • Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento: Documento de consenso

    Josep M. Campistol;Manuel Arias;Gema Ariceta;Miguel Blasco

  • Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).

    Yves Vanrenterghem;Barbara Bresnahan;Josep Campistol;Antoine Durrbach

Frequent Co-Authors

Flavio Vincenti
Flavio Vincenti University of California, San Francisco
Josep M. Campistol
Josep M. Campistol University of Barcelona
Klemens Budde
Klemens Budde Charité - University Medicine Berlin
August Vidal
August Vidal University of Barcelona
Lionel Rostaing
Lionel Rostaing Grenoble Alpes University
Dirk Kuypers
Dirk Kuypers KU Leuven
Christian P. Larsen
Christian P. Larsen Emory University
Christophe Legendre
Christophe Legendre Necker-Enfants Malades Hospital
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but seeking alternative or complementary career routes, online education offers flexible options. Programs such as a nutrition bachelor degree online prepare students for roles in health promotion, public health, and dietetics. Nutrition science can be a great fit for those who want to focus on wellness, preventive care, and education.

For those aspiring to healthcare leadership, many choose cahme accredited mha online programs. Earning a Master of Health Administration opens doors to management, policy-making, and quality improvement within hospital systems and clinics.

Registered nurses looking to advance their education without additional hands-on requirements might consider rn to bsn online programs without clinicals. These programs streamline the path to a Bachelor of Science in Nursing for working professionals.

Advanced nursing practitioners seeking the fastest route to the highest level of clinical education may benefit from the shortest post master's dnp program. This allows experienced nurses to move quickly toward leadership and specialized clinical roles.

These diverse online pathways offer accessible routes to rewarding careers throughout the healthcare sector.

Best Scientists Citing Josep M. Grinyó

Trending Scientists

Recently Published Articles